Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/19/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Gordon Chiu

Wrong Dr. Gordon Chiu?

Vice President and Chief Scientis...

Grafoid Inc
912-130 Albert Street
Ottawa, Ontario K1P 5G4
Canada

Company Description: Grafoid's mission creates markets for our graphene investments to institutional partners, and we provide technical advisory and consulting services to miners,...   more
Background

Employment History

Board Memberships and Affiliations

  • Board Member
    Vois Inc.
  • Board Member
    Mimvi , Inc.
  • Founder
    Depression Think Tank

Education

  • Bachelors of Science ( Summa Cum Laude , Chemistry
    Rensselaer Polytechnic Institute
  • Masters
    The Merck Graduate School
  • Masters of Science , Chemisty
  • Bachelors of Science ( Summa Cum Laude ) , Chemistry
    Rensselaer Polytechnic Institute
  • Masters
    Seton Hall University
89 Total References
Web References
Graphite Stocks | Focus Graphite
graphitestocks.com, 19 Dec 2013 [cached]
Dr. Gordon Chiu, B.Sci, M.Sci, MSTP recipient, ND.
Dr. Gordon Chiu is Vice President and Chief Scientist of Grafoid inc., Focus Metals' joint venture to develop, patent and secure the global rights for specific graphene technologies. The joint venture is based in New York City.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. A lecturer and corporate advisor, Dr Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and provides advice on project selection with a view to increasing overall shareholder value.
Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. He holds a B.S. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an M.S. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine. He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.
Gordon Chiu, B.Sci., MSci, ...
www.calevia.com, 10 Oct 2013 [cached]
Gordon Chiu, B.Sci., MSci, f-MSTP, ND
...
Dr. Chiu is lead advisor to Calevia Inc. and will co-manage the project. He is Co-Founder and Vice-President of Grafoid Inc., a privately held Canadian corporation investing in graphene applications and economically scalable production processes for MesoGraf™ - the global standard for graphene - and MesoGraf™Xide, its trademark graphene oxide produced from raw, unprocessed graphite ore.
Dr. Chiu is also the lead scientist at Focus Graphite, a TSX Venture-listed graphite mining and graphene development company.
This Board is led by Dr. ...
www.sec.gov, 18 April 2013 [cached]
This Board is led by Dr. Gordon Chiu. Dr. Chiu has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. He has been invited to serve on the board of public and private companies and to provide vital advice to the board while increasing overall shareholder value. Dr. Chiu's background and broad experience has allowed him to act as an advisor in areas of Alzheimer research, breast cancer research, dermatology, drug addictions research, green technology and antimicrobial research. Dr. Chiu has worked as a research scientist for both Pfizer (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK). He graduated with a B.S. degree from Rensselaer Polytechnic Institute with a summa cum laude. He graduated with an M.S. degree from Seton Hall University. Additionally, Dr. Chiu was accepted as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program for four years at the Mount Sinai School of Medicine where he also researched, developed, consulted and advised the Department of Dermatology's Dr. Huachen Wei in skin cancer research. Seeing the opportunity to impact foreign policies in healthcare, he transferred his credentials to University of Bridgeport School of Naturopathic Medicine to receive his doctorate in naturopathic medicine. With this unique background, he has been chosen to serve in an advisory role in the identification of low cost Technologies (i.e. non-invasive diagnostic equipment) for emerging countries. His years of continuous involvement have created deep relationships within the scientific, business, and medical communities.
Mimvi - About Management
www.mimvi.com, 26 Nov 2012 [cached]
Dr. Gordon Chiu Dr. Chiu is an execution driven businessman with more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. He has been invited to serve on the board of public and private companies and to provide vital advice to the board while increasing overall shareholder value. Dr. Chiu's background and experience has led to numerous accomplishments across fields, including: Alzheimer research, breast cancer research, dermatology, drug addictions research, green technology and antimicrobial research. He started his career as a research scientist at Pfizer Inc and Merck & Co. Inc. His healthcare and marketing experience includes strong links to both Wall Street and Asia.
Dr. Chiu's educational background began with a B.S. degree in Chemistry from Rensselaer Polytechnic Institute with a summa cum laude. He graduated with an M.S. degree in Chemistry from Seton Hall University with high honors. Additionally, Dr. Chiu was accepted as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program for four years at the Mount Sinai School of Medicine where he also researched, developed, consulted and advised the Department of Dermatology's Dr. Huachen Wei in skin cancer research. Seeing the opportunity to impact foreign policies in healthcare, he transferred his credentials to University of Bridgeport School of Naturopathic Medicine where he received his doctorate in naturopathic medicine.
With this unique background, he has investigated the validity of foreign treatments and their success level for public health. He has also been chosen to serve an advisory role in the identification of low cost solutions (i.e. non-invasive diagnostic equipment) for emerging countries that cannot afford to maintain armies of physicians across numerous sub-specialties. Dr. Chiu developed and owns methodologies called directed combinatorial algorithmic libraries (D.C.A.L.) that are used in various commercial applications, composition development and research.
I would like to also recognize ...
grafoid.com, 23 May 2013 [cached]
I would like to also recognize Dr. Gordon Chiu, who is Chief Scientist at Focus Graphite and a co-founder and Vice President of Grafoid Inc.
...
Dr. Chiu and Dr. Loh, the named inventors of this process are to be congratulated for their efforts.
...
Dr. Chiu will provide a more detailed, technical summary of our top-down process and MesoGraf's properties.
Other People with the name "Chiu":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.